| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 87,395 | 89,263 | 92,678 | 95,010 | | Cost of Revenue | 73,827 | 75,499 | 73,981 | 78,327 | | | Gross Profit | 13,568 | 13,764 | 18,697 | 16,683 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 9,354 | 10,094 | 9,657 | 10,217 | | Non Recurring |
-
| (74) | (419) | 20 | | Others | 439 | 435 | 437 | 440 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 3,834 | 3,309 | 9,022 | 6,006 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 609 | 439 | 62 | (1,645) | | Earnings Before Interest And Taxes | (10,934) | 3,748 | 9,084 | 4,361 | | Interest Expense | (9,997) | 4,978 | 5,019 | 5,807 | | Income Before Tax | (937) | (1,230) | 4,065 | (1,446) | | Income Tax Expense | (551) | (362) | 1,824 | (362) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (386) | (868) | 2,241 | (1,084) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (386) | (868) | 2,241 | (1,084) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($386) | ($868) | $2,241 | ($1,084) |
|
1.52% Nasdaq 0.00%
Income Statement
